Physician profile
Ted Tk Lin
NPI 1730346966
$6,165.01
in general payments reported to CMS, 2019-2025
24 companies · $347 in 2025
The $347 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,750 · 2020: $394 · 2021: $581 · 2022: $570 · 2023: $788 · 2024: $736 · 2025: $347.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,870.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,870.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $2,383.84 | 2019-2020 | |
| Medtronic, INC. | $1,793.57 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Vectris Surescan |
| Saluda Medical Americas, INC. | $336.74 | 2022-2024 | Evoke, Evoke Scs |
| Nevro Corp. | $262.96 | 2021-2022 | |
| Abbott Laboratories | $251.23 | 2019-2020 | |
| Nalu Medical, INC. | $187.76 | 2021 | |
| Boston Scientific Corporation | $175.89 | 2019-2024 | Wavewriter Alpha Prime 16 |
| Medtronic Vascular, INC. | $172.23 | 2019-2020 | |
| Vertiflex, INC. | $97.71 | 2019 | |
| Vertos Medical, INC. | $79.91 | 2020-2024 | Mild Device Kit |
| Painteq LLC | $78.38 | 2023-2024 | Painteq |
| Curonix LLC | $67.67 | 2023-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Stimwave Technologies Incorporated | $58.42 | 2020-2022 | |
| Covidien LP | $54.40 | 2019 | |
| Epimed International, INC | $19.55 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $18.89 | 2022 | |
| Spinal Simplicity, LLC | $18.85 | 2021 | |
| Novartis Pharmaceuticals Corporation | $17.90 | 2019 | |
| Allergan, INC. | $17.73 | 2019 | |
| Collegium Pharmaceutical, INC. | $17.07 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $14.69 | 2019 | |
| Arbor Pharmaceuticals, INC. | $14.24 | 2021 | |
| Fidia Pharma USA INC. | $12.94 | 2023 | Hymovis, Triluron |
| Sentynl Therapeutics, INC. | $12.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ted Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.